Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,725 |
|
|||||
| News | - | ||||||
| Day High | 3.09 | Low High |
|||||
| Day Low | 2.959 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.054 | 1.86% | 2.959 | 10:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.09 | 2.959 | 3.09 | 2.959 | 2.905 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 64 | 1,725 | US$ 2.97 | US$ 5,128 | - | 1.62 - 4.05 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:17:40 | 8 | US$ 2.99 | USD |
Anebulo Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 76.76M | 25.93M | - | 0 | -11.73M | -0.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Anebulo Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 14/2/2024 | 08:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14/2/2024 | 08:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14/2/2024 | 08:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
| 22/11/2023 | 08:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/11/2023 | 08:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
| 31/10/2023 | 00:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 31/10/2023 | 00:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 20/10/2023 | 08:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 07/10/2023 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/10/2023 | 07:06 | Business Wire | Anebulo Pharmaceuticals Announces New CEO |
| 03/10/2023 | 08:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 23/9/2023 | 06:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
Historical ANEB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.79 | 3.10 | 2.60 | 2.83 | 8,815 | 0.169 | 6.06% |
| 1 Month | 2.41 | 3.14 | 2.40 | 2.75 | 6,043 | 0.549 | 22.78% |
| 3 Months | 2.40 | 3.30 | 2.35 | 2.69 | 5,955 | 0.559 | 23.29% |
| 6 Months | 2.47 | 3.30 | 1.62 | 2.36 | 13,578 | 0.489 | 19.80% |
| 1 Year | 2.90 | 4.05 | 1.62 | 2.49 | 9,626 | 0.059 | 2.03% |
| 3 Years | 7.38 | 9.33 | 1.62 | 4.63 | 10,582 | -4.42 | -59.91% |
| 5 Years | 7.38 | 9.33 | 1.62 | 4.63 | 10,582 | -4.42 | -59.91% |
